Who Buys Febuxostat from India — 421 Importers Behind a $48.9M Market
India's febuxostat import market is served by 421 active buyers who collectively imported $48.9M across 3,494 shipments. UNILAB INC (PHILIPPINES) leads with a 18.1% market share, followed by AJANTA PHARMA PHILIPPINES INC and MULTICARE PHARMACEUTICALS. The top 5 buyers together control 50.0% of total import value, reflecting a moderately competitive buyer landscape.
Top Febuxostat Importers — Ranked by Import Value
UNILAB INC (PHILIPPINES) is the leading febuxostat importer from India, holding a 18.1% share of the $48.9M market across 3,494 shipments from 421 buyers. The top 5 buyers — UNILAB INC (PHILIPPINES), AJANTA PHARMA PHILIPPINES INC (PHILIPPINES), MULTICARE PHARMACEUTICALS (PHILIPPINES), J. KNIPPER & COMPANY, (UNITED STATES), J KNIPPER COMPANY (UNITED STATES) — collectively control 50.0% of total import value.
Top Febuxostat Buyers & Importers
Ranked by import value · 421 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | UNILAB INCPHILIPPINES URINORM TAB 40MG FEBUXOSTAT TABLETS 40URINORM TAB 40MG (FEBUXOSTAT TABLETS 40FURIC 40 10X10T FEBUXOSTAT TABLETS 40MG | $8.9M | 5 | 18.1% |
| 2 | AJANTA PHARMA PHILIPPINES INCPHILIPPINES URINORM TAB 40MG FEBUXOSTAT TABLETS 40URINORM TAB 40MG (FEBUXOSTAT TABLETS 40FURIC 40 10X10T FEBUXOSTAT TABLETS 40MG | $7.6M | 5 | 15.6% |
| 3 | MULTICARE PHARMACEUTICALSPHILIPPINES URINORM TAB 40MG FEBUXOSTAT TABLETS 40URINORM TAB 40MG (FEBUXOSTAT TABLETS 40FURIC 40 10X10T FEBUXOSTAT TABLETS 40MG | $3.9M | 5 | 8.0% |
| 4 | J. KNIPPER & COMPANY,UNITED STATES FEBUXOSTAT TABLETS 40MG 30 S AP USFEBUXOSTAT TABLETS 80MG 30'S AP USFEBUXOSTAT TABLETS 40MG 30'S AP US | $2.7M | 5 | 5.6% |
| 5 | J KNIPPER COMPANYUNITED STATES URINORM TAB 40MG FEBUXOSTAT TABLETS 40URINORM TAB 40MG (FEBUXOSTAT TABLETS 40FEBUXOSTAT TABLETS 40MG 30 S AP US | $1.3M | 5 | 2.7% |
| 6 | MULTICARE PHARMACEUTICALS PHILIPPINPHILIPPINES URINORM TAB 40MG FEBUXOSTAT TABLETS 40URINORM TAB 40MG (FEBUXOSTAT TABLETS 40FURIC 40 10X10T FEBUXOSTAT TABLETS 40MG | $1.2M | 5 | 2.4% |
| 7 | MARCAN PHARMACEUTICALS INCCANADA MAR FEBUXOSTAT TABLETS 80MG 100T CAMAR-FEBUXOSTAT TABLETS 80MG 100T CA,BATCMAR-FEBUXOSTAT TABLETS 80MG 100T CA BATC | $1.0M | 5 | 2.1% |
| 8 | TEVA PHARMACEUTICALS WORKS PVT LTDHUNGARY FEBUXOSTAT FILM COATED TABLETS 80 MG 5 KFEBUXOSTAT FILM COATED TABLETS 80 MG 5 KG (FEBUXOSTAT FILM COATED TABLETS 80 MG 5 KG | $840.6K | 5 | 1.7% |
| 9 | J. KNIPPER & COMPANYUNITED STATES FEBUXOSTAT TABLETS 40MG 30 S AP USFEBUXOSTAT TABLETS 80MG 30'S AP USFEBUXOSTAT TABLETS 40MG 30'S AP US | $840.4K | 5 | 1.7% |
| 10 | NOVADOZ PHARMACEUTICALS LLCUNITED STATES FEBUXOSTAT TABLETS 40MG 30 S AP USFEBUXOSTAT TABLETS 80MG 30'S AP USFEBUXOSTAT TABLETS 40MG 30'S AP US | $607.5K | 5 | 1.2% |
| 11 | MACLEODS PHARMA UK LIMITEDUNITED KINGDOM FEBUXOSTAT TABLETS 40MG 30 S AP USFEBUXOSTAT TABLETS 80MG 30'S AP USFEBUXOSTAT TABLETS 40MG 30'S AP US | $581.0K | 5 | 1.2% |
| 12 | MARCAN PHARMACEUTICALS INC.CANADA MAR FEBUXOSTAT TABLETS 80MG 100T CAMAR-FEBUXOSTAT TABLETS 80MG 100T CA,BATCMAR-FEBUXOSTAT TABLETS 80MG 100T CA BATC | $574.2K | 5 | 1.2% |
| 13 | EVERSANA LIFE SCIENCE SERVICESUNITED STATES FEBUXOSTAT TABLETS 40MG 30 S AP USFEBUXOSTAT TABLETS 80MG 30'S AP USFEBUXOSTAT TABLETS 40MG 30'S AP US | $542.2K | 5 | 1.1% |
| 14 | NORTHSTAR DISTRIBUTION CENTER 8912UNITED STATES FEBUXOSTAT TABLETS 40MG 30 S AP USFEBUXOSTAT TABLETS 80MG 30'S AP USFEBUXOSTAT TABLETS 40MG 30'S AP US | $537.0K | 5 | 1.1% |
| 15 | J.KNIPPER & COMPANYUNITED STATES FEBUXOSTAT TABLETS 40MG 30 S AP USFEBUXOSTAT TABLETS 80MG 30'S AP USFEBUXOSTAT TABLETS 40MG 30'S AP US | $533.3K | 5 | 1.1% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Febuxostat — and from which countries?
Flow of Febuxostat exports from India: each country's share and the named importers behind the numbers
Febuxostat — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Philippines
Philippines emerges as the first largest importing country, achieving a total trade value of $25.6M through 95 shipments. This represents a market share of 52.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Philippines has a diverse importer base, with their top importers including:
• UNILAB INC - $8.9M (34.6% of country's total business)
• AJANTA PHARMA PHILIPPINES INC - $7.6M (29.8% of country's total business)
• MULTICARE PHARMACEUTICALS - $3.9M (15.3% of country's total business)
• MULTICARE PHARMACEUTICALS PHILIPPIN - $1.2M (4.5% of country's total business)
• OLLEN PHARMA TRADING INC - $340.2K (1.3% of country's total business)
• Rest of Philippines's importers - $3.7M (14.3% of country's total business)
Key Insight: Philippines demonstrates strong market positioning with an average shipment value of $269.2K, indicating premium pricing strategy compared to the market average of $14.0K.
Philippines is a key market for Febuxostat imports, representing 52.3% of total trade value.
2United States
United States emerges as the second largest importing country, achieving a total trade value of $11.6M through 98 shipments. This represents a market share of 23.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• J. KNIPPER & COMPANY, - $2.7M (23.4% of country's total business)
• J KNIPPER COMPANY - $1.3M (11.5% of country's total business)
• J. KNIPPER & COMPANY - $840.4K (7.2% of country's total business)
• NOVADOZ PHARMACEUTICALS LLC - $607.5K (5.2% of country's total business)
• EVERSANA LIFE SCIENCE SERVICES - $542.2K (4.7% of country's total business)
• Rest of United States's importers - $5.6M (47.9% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $118.4K, indicating premium pricing strategy compared to the market average of $14.0K.
United States is a key market for Febuxostat imports, representing 23.7% of total trade value.
3Canada
Canada emerges as the third largest importing country, achieving a total trade value of $2.4M through 26 shipments. This represents a market share of 4.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• MARCAN PHARMACEUTICALS INC - $1.0M (42.5% of country's total business)
• MARCAN PHARMACEUTICALS INC. - $574.2K (24.3% of country's total business)
• JAMP PHARMA CORPORATION - $362.1K (15.3% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $91.1K, indicating premium pricing strategy compared to the market average of $14.0K.
Canada is a key market for Febuxostat imports, representing 4.8% of total trade value.
4Hungary
Hungary emerges as the fourth largest importing country, achieving a total trade value of $1.3M through 20 shipments. This represents a market share of 2.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Hungary has a diverse importer base, with their top importers including:
• TEVA PHARMACEUTICALS WORKS PVT LTD - $840.6K (62.8% of country's total business)
• TEVA PHARMACEUTICALS WORKS PRIVATE LIMITED - $497.3K (37.2% of country's total business)
Key Insight: Hungary demonstrates strong market positioning with an average shipment value of $66.9K, indicating premium pricing strategy compared to the market average of $14.0K.
Hungary is a key market for Febuxostat imports, representing 2.7% of total trade value.
5United Kingdom
United Kingdom emerges as the fifth largest importing country, achieving a total trade value of $1.2M through 16 shipments. This represents a market share of 2.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Kingdom has a diverse importer base, with their top importers including:
• MACLEODS PHARMA UK LIMITED - $581.0K (47.8% of country's total business)
Key Insight: United Kingdom demonstrates strong market positioning with an average shipment value of $75.9K, indicating premium pricing strategy compared to the market average of $14.0K.
United Kingdom is a key market for Febuxostat imports, representing 2.5% of total trade value.
Buyer Segment Analysis
TransData Nexus Febuxostat buyer market intelligence
1Buyer Segment Analysis
The 421 buyers of Febuxostat imported from India can be categorized into several segments:
- Distributors: Entities like UNILAB INC and AJANTA PHARMA PHILIPPINES INC in the Philippines, and J. KNIPPER & COMPANY in the United States, function as intermediaries, purchasing large quantities to supply to pharmacies, hospitals, and clinics. Their buying behavior is characterized by bulk purchases and a high repeat buyer rate, reflecting ongoing demand.
- Hospital Groups: Organizations such as MULTICARE PHARMACEUTICALS in the Philippines procure Febuxostat to meet the needs of their affiliated hospitals and clinics. Their purchasing patterns are influenced by patient demand and formulary requirements, often resulting in consistent, sizable orders.
- Retail Chains: Companies like MARCAN PHARMACEUTICALS INC in Canada and NOVADOZ PHARMACEUTICALS LLC in the United States supply Febuxostat directly to consumers through their pharmacy outlets. They typically place regular orders to maintain stock levels, ensuring availability for patients.
- Contract Manufacturers: Entities such as TEVA PHARMACEUTICALS WORKS PVT LTD in Hungary may import Febuxostat for further processing or packaging before distribution. Their procurement is often based on production schedules and market demand forecasts.
Each segment's purchasing behavior reflects their role in the supply chain, with distributors and hospital groups focusing on bulk procurement, retail chains on consistent stock replenishment, and contract manufacturers on aligning imports with production needs.
Country-Specific Import Regulations
TransData Nexus Febuxostat buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Febuxostat are as follows:
- Philippines:
- Regulatory Authority: Food and Drug Administration (FDA) Philippines.
- Import Registration Process: Importers must obtain a License to Operate (LTO) and secure a Certificate of Product Registration (CPR) for Febuxostat.
- Estimated Timeline: The registration process typically takes 6 to 12 months.
- Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally subject to a 0% import duty, but importers should verify current rates with the Bureau of Customs.
- United States:
- Regulatory Authority: U.S. Food and Drug Administration (FDA).
- Import Registration Process: Importers must ensure Febuxostat is FDA-approved. Facilities involved in manufacturing, processing, or packaging must register with the FDA.
- Estimated Timeline: The approval process can range from several months to over a year, depending on the submission type.
- Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are typically duty-free, but importers should confirm with U.S. Customs and Border Protection.
- Canada:
- Regulatory Authority: Health Canada.
- Import Registration Process: Importers must obtain a Drug Establishment License (DEL) and ensure Febuxostat has a Notice of Compliance (NOC) and Drug Identification Number (DIN).
- Estimated Timeline: The registration process usually takes 12 to 18 months.
- Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally duty-free, but importers should verify with the Canada Border Services Agency.
- Hungary:
- Regulatory Authority: National Institute of Pharmacy and Nutrition (OGYÉI).
- Import Registration Process: Importers must obtain a marketing authorization for Febuxostat.
- Estimated Timeline: The registration process typically takes 12 to 15 months.
- Import Tariff/Duty: As an EU member, Hungary applies the EU's Common External Tariff, which is 0% for pharmaceutical products under HS Code 30049099.
- United Kingdom:
- Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
- Import Registration Process: Importers must obtain a Wholesale Dealer's License and ensure Febuxostat has a Marketing Authorization.
- Estimated Timeline: The registration process usually takes 12 to 18 months.
- Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally duty-free, but importers should confirm with HM Revenue & Customs.
Importers are advised to consult the respective regulatory authorities for the most current information, as regulations and tariffs are subject to change.
Demand Drivers & Market Opportunity
TransData Nexus Febuxostat buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Febuxostat is primarily driven by the prevalence of gout and hyperuricemia in importing countries. Gout affects approximately 1-4% of adults globally, with higher rates in developed nations. For instance, in the United States, gout prevalence is about 3.9%, affecting over 9 million adults. The Philippines also reports a significant incidence of gout, contributing to the substantial importation of Febuxostat.
Government healthcare programs and the expansion of universal health coverage further bolster demand. Countries like Canada and the United Kingdom have comprehensive healthcare systems that cover medications for chronic conditions, including gout. Additionally, the inclusion of Febuxostat in national formularies and its procurement through tender-based purchasing systems, as recommended by the World Health Organization, enhance accessibility and affordability. The presence of 421 buyers across 91 countries underscores the global demand and market opportunity for Febuxostat.
Common Questions — Febuxostat Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest febuxostat buyer importing from India?
Based on import volume and value, UNILAB INC (PHILIPPINES) leads with $8.9M in imports and a 18.1% market share — the highest of any single febuxostat importer. AJANTA PHARMA PHILIPPINES INC (PHILIPPINES) and MULTICARE PHARMACEUTICALS (PHILIPPINES) are the next largest buyers.
QHow many companies buy febuxostat from India?
There are 421 active febuxostat buyers importing from India, with a combined market of $48.9M across 3,494 shipments to 91 countries. The top 5 buyers hold 50.0% of total import value, while the remaining 416 buyers handle the other 50.0%.
QWhich countries import the most febuxostat from India?
The top importing countries for febuxostat from India are Philippines (52.3%), United States (23.7%), Canada (4.8%), Hungary (2.7%), United Kingdom (2.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of febuxostat, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for febuxostat from India?
The average import transaction value for febuxostat from India is $14.0K, with an average unit price of $4.61 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Febuxostat buyer market intelligence
1Buyer Segment Analysis
The 421 buyers of Febuxostat imported from India can be categorized into several segments:
- Distributors: Entities like UNILAB INC and AJANTA PHARMA PHILIPPINES INC in the Philippines, and J. KNIPPER & COMPANY in the United States, function as intermediaries, purchasing large quantities to supply to pharmacies, hospitals, and clinics. Their buying behavior is characterized by bulk purchases and a high repeat buyer rate, reflecting ongoing demand.
- Hospital Groups: Organizations such as MULTICARE PHARMACEUTICALS in the Philippines procure Febuxostat to meet the needs of their affiliated hospitals and clinics. Their purchasing patterns are influenced by patient demand and formulary requirements, often resulting in consistent, sizable orders.
- Retail Chains: Companies like MARCAN PHARMACEUTICALS INC in Canada and NOVADOZ PHARMACEUTICALS LLC in the United States supply Febuxostat directly to consumers through their pharmacy outlets. They typically place regular orders to maintain stock levels, ensuring availability for patients.
- Contract Manufacturers: Entities such as TEVA PHARMACEUTICALS WORKS PVT LTD in Hungary may import Febuxostat for further processing or packaging before distribution. Their procurement is often based on production schedules and market demand forecasts.
Each segment's purchasing behavior reflects their role in the supply chain, with distributors and hospital groups focusing on bulk procurement, retail chains on consistent stock replenishment, and contract manufacturers on aligning imports with production needs.
Country-Specific Import Regulations
TransData Nexus Febuxostat buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Febuxostat are as follows:
- Philippines:
- Regulatory Authority: Food and Drug Administration (FDA) Philippines.
- Import Registration Process: Importers must obtain a License to Operate (LTO) and secure a Certificate of Product Registration (CPR) for Febuxostat.
- Estimated Timeline: The registration process typically takes 6 to 12 months.
- Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally subject to a 0% import duty, but importers should verify current rates with the Bureau of Customs.
- United States:
- Regulatory Authority: U.S. Food and Drug Administration (FDA).
- Import Registration Process: Importers must ensure Febuxostat is FDA-approved. Facilities involved in manufacturing, processing, or packaging must register with the FDA.
- Estimated Timeline: The approval process can range from several months to over a year, depending on the submission type.
- Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are typically duty-free, but importers should confirm with U.S. Customs and Border Protection.
- Canada:
- Regulatory Authority: Health Canada.
- Import Registration Process: Importers must obtain a Drug Establishment License (DEL) and ensure Febuxostat has a Notice of Compliance (NOC) and Drug Identification Number (DIN).
- Estimated Timeline: The registration process usually takes 12 to 18 months.
- Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally duty-free, but importers should verify with the Canada Border Services Agency.
- Hungary:
- Regulatory Authority: National Institute of Pharmacy and Nutrition (OGYÉI).
- Import Registration Process: Importers must obtain a marketing authorization for Febuxostat.
- Estimated Timeline: The registration process typically takes 12 to 15 months.
- Import Tariff/Duty: As an EU member, Hungary applies the EU's Common External Tariff, which is 0% for pharmaceutical products under HS Code 30049099.
- United Kingdom:
- Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
- Import Registration Process: Importers must obtain a Wholesale Dealer's License and ensure Febuxostat has a Marketing Authorization.
- Estimated Timeline: The registration process usually takes 12 to 18 months.
- Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally duty-free, but importers should confirm with HM Revenue & Customs.
Importers are advised to consult the respective regulatory authorities for the most current information, as regulations and tariffs are subject to change.
Demand Drivers & Market Opportunity
TransData Nexus Febuxostat buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Febuxostat is primarily driven by the prevalence of gout and hyperuricemia in importing countries. Gout affects approximately 1-4% of adults globally, with higher rates in developed nations. For instance, in the United States, gout prevalence is about 3.9%, affecting over 9 million adults. The Philippines also reports a significant incidence of gout, contributing to the substantial importation of Febuxostat.
Government healthcare programs and the expansion of universal health coverage further bolster demand. Countries like Canada and the United Kingdom have comprehensive healthcare systems that cover medications for chronic conditions, including gout. Additionally, the inclusion of Febuxostat in national formularies and its procurement through tender-based purchasing systems, as recommended by the World Health Organization, enhance accessibility and affordability. The presence of 421 buyers across 91 countries underscores the global demand and market opportunity for Febuxostat.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 421 global importers of Febuxostat identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 3,494 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 91 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,494 Verified Shipments
421 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists